Evidence map›Paper›PMID 29545804›Full record

ArticleFrontiers in immunology2018

Persistent Intracellular

Anas H Abu-Humaidan, Malin Elvén, Andreas Sonesson, Peter Garred, Ole E Sørensen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. The Complex Intracellular Lifecycle ofInternational journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Mass Spectrometry Analysis of Shark Skin Proteins.International journal of molecular sciences · 2023
    Review
  8. Chemical and biomolecular insights into theIsrael journal of chemistry · 2023
    Article
  9. Multiple Proteins ofFrontiers in microbiology · 2022
    Article
  10. Inflammatory Response AgainstFrontiers in immunology · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Multi-functionalized nanocarriers targeting bacterial reservoirs to overcome challenges of multi drug-resistance.Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences · 2020
    Review
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Anas H Abu-HumaidanDepartment of Clinical Sciences Lund, Infection Medicine, Lund University, Lund, Sweden.
Malin ElvénSkåne University Hospital, Department of Clinical Sciences Lund, Dermatology and Venereology, Lund University, Lund, Sweden.
Andreas SonessonSkåne University Hospital, Department of Clinical Sciences Lund, Dermatology and Venereology, Lund University, Lund, Sweden.
Peter GarredLaboratory of Molecular Medicine, Department of Clinical Immunology Section 7631, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Ole E SørensenSkåne University Hospital, Department of Clinical Sciences Lund, Dermatology and Venereology, Lund University, Lund, Sweden.
Skåne University Hospital · SECopenhagen University Hospital · DKLund University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The complement system is an ancient part of the innate immune system important for both tissue homeostasis and host defense. However, bacteria like

Indexed as

Bacterial LoadCells, CulturedComplement ActivationComplement Membrane Attack ComplexComplement System ProteinsHumansImmune EvasionKeratinocytesMAP Kinase Signaling SystemMicroscopy, FluorescencePhagocytosisSkinStaphylococcal InfectionsStaphylococcus aureusComplement Membrane Attack ComplexComplement System Proteinsatopic dermatitisclassical pathway activationcomplement activationErk activationintracellular infectionmembrane attack complexStaphylococcus aureus

Identifiers

PMID29545804
PMCPMC5837974
OpenAlexW2790530044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.